STOCK TITAN
  1. Home
  2. Sec-filings
  3. MRMD
  4. [Form 4] MARIMED INC. Insider Trading Activity

MariMed (MRMD) CEO awarded 122,500 RSUs and reports updated holdings

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Levine Jon R reported acquisition or exercise transactions in this Form 4 filing.

MariMed Inc. President and CEO Jon R. Levine received a grant of 122,500 Restricted Stock Units (RSUs), each convertible into one share of common stock. The RSUs will vest in four equal installments on July 15, 2026, October 15, 2026, January 15, 2027, and April 15, 2027. After this grant, he holds 21,158,974 shares of common stock directly, and 6,684,640 additional shares are held by the Jon Levine Family Trust for the benefit of his spouse and children, for which he disclaims beneficial ownership.

Positive

  • None.

Negative

  • None.
Insider Levine Jon R
Role President and CEO
Type Security Shares Price Value
Grant/Award Restricted Stock Units (RSU) 122,500 $0.00 --
holding Common stock -- -- --
holding Common stock -- -- --
Holdings After Transaction: Restricted Stock Units (RSU) — 122,500 shares (Direct); Common stock — 21,158,974 shares (Direct); Common stock — 6,684,640 shares (Indirect, By the Jon Levine Family Trust)
Footnotes (1)
  1. These shares are held in trust for the benefit of the Reporting Person's spouse and children. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. RSUs convert to shares of common stock on a one-for-one basis. The RSUs will vest in four equal installments on each of July 15, 2026, October 15, 2026, January 15, 2027 and April 15, 2027.
RSU grant size 122,500 RSUs Granted on April 15, 2026; one-for-one into common stock
Direct common shares after transaction 21,158,974 shares Direct ownership following April 15, 2026 reporting
Family trust common shares 6,684,640 shares Held by the Jon Levine Family Trust; beneficial ownership disclaimed
RSU vesting dates July 15 & Oct 15, 2026; Jan 15 & Apr 15, 2027 Four equal installments over 2026–2027
Restricted Stock Units (RSU) financial
"The 122,500 RSUs will vest in four equal installments"
beneficial ownership financial
"The Reporting Person disclaims beneficial ownership of these securities"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Section 16 regulatory
"beneficial owner of these securities for purposes of Section 16"
Section 16 is a U.S. securities law rule that governs the trading and disclosure obligations of company insiders — typically officers, directors and large shareholders — to promote transparency and deter unfair profit-taking. It requires insiders to publicly report their stock trades and allows companies or the issuer to reclaim quick, short-term profits from certain insider trades, like a scoreboard and a refund policy that help investors see and limit possible insider advantage.
Family Trust financial
"These shares are held in trust for the benefit of the Reporting Person's spouse and children"
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Levine Jon R
(Last)(First)(Middle)
C/O MARIMED INC.
10 OCEANA WAY
(Street)
NORWOOD, MASSACHUSETTS 02062
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
MARIMED INC. [ MRMD ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirectorX10% Owner
XOfficer (give title below)Other (specify below)
President and CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/15/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common stock21,158,974D
Common stock6,684,640IBy the Jon Levine Family Trust(1)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Restricted Stock Units (RSU)(2)04/15/2026A122,500 (3) (3)Common Stock, par value $.001 per share122,500$0122,500D
Explanation of Responses:
1. These shares are held in trust for the benefit of the Reporting Person's spouse and children. The Reporting Person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
2. RSUs convert to shares of common stock on a one-for-one basis.
3. The RSUs will vest in four equal installments on each of July 15, 2026, October 15, 2026, January 15, 2027 and April 15, 2027.
Remarks:
The RSUs were granted in lieu of cash payment of a portion of the Reporting Person's annual bonus for the fiscal year ended December 31, 2025.
/s/ Jon R. Levine04/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did MRMD President and CEO Jon Levine report?

Jon Levine reported receiving a grant of 122,500 Restricted Stock Units (RSUs). These RSUs are a form of equity compensation that convert into common stock on a one-for-one basis as they vest over time.

How do the new RSUs for MRMD’s CEO vest over time?

The 122,500 RSUs vest in four equal installments. Vesting dates are July 15, 2026, October 15, 2026, January 15, 2027, and April 15, 2027, gradually delivering shares as long as vesting conditions are satisfied.

How many MRMD common shares does Jon Levine hold directly after this filing?

Following the RSU grant, Jon Levine holds 21,158,974 shares of MariMed common stock directly. This figure reflects his direct ownership position as reported in the Form 4 after the April 15, 2026 transactions.

What MRMD shares are held through the Jon Levine Family Trust?

The Jon Levine Family Trust holds 6,684,640 MRMD common shares for the benefit of his spouse and children. The filing states that Levine disclaims beneficial ownership of these securities for Section 16 and other purposes.

What does it mean that MRMD RSUs convert one-for-one into common stock?

The filing specifies that each RSU converts into one share of MariMed common stock. When RSUs vest on the scheduled dates, the holder receives one share for each unit, subject to any applicable company or tax requirements.

What is the significance of a Form 4 filing for MRMD investors?

A Form 4 shows transactions and holdings by MariMed insiders such as directors and officers. It details grants like the 122,500 RSUs to the CEO and reports updated direct and indirect share ownership positions after the reported date.